CellaVision Annual General Meeting 2025 will take place on May 6

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

Shareholders who wish to participate in the AGM shall be registered in the share register maintained by Euroclear Sweden AB no later than on 25 April 2025 andshall have notified the Company of their intention to participate at the AGM no later than on 29 April 2025. Notice to participate shall be given in writing by e-mail to cellavision@fredersen.se or by post to CellaVision AB (publ), c/o Fredersen Advokatbyrå, Neptunigatan 82, 211 18 Malmö. The notice shall contain the shareholder’s name, personal identity number or registration number and telephone number and, where applicable, the number of advisors (maximum two).

Attachments

CellaVision AB - Kallelse ÅS 2025.pdf CellaVision AB - Notice AGM 2025.pdf CellaVision AB - Fullmaktsformulär (Årsstämma 2025).pdf CellaVision AB - Proxy form (AGM 2025).pdf Valberedningens förslag och motiverande yttrande.PDF The Nomination Committees proposal and motivated statement.PDF Presentation av föreslagna styrelseledamöter 2025.pdf Presentation of proposed board members 2025.pdf Riktlinjer 2025.pdf Guidelines 2025.pdf Styrelsens fullständiga förslag förvärv och återköp egna aktier (punkt 20).pdf The Board's proposal on authorization for the Board to repurchase and transfer own shares (item 20).pdf Styrelsens motiverade yttrande enl. 19.22.pdf The Board's motivated statement pursuant to 19.22.pdf Auditors opinion (Swe).pdf Cellavision Ersättningsrapport 2024.pdf CellaVision Remuneration report 2024.pdf Proposal of the board of directors distribution of profits (Swe).pdf CellaVision - Stämmoprotokoll ÅS 2025 inkl. bilagor.pdf